3.11
-0.24(-7.16%)
Currency In USD
Previous Close | 3.35 |
Open | 3.3 |
Day High | 3.3 |
Day Low | 3.03 |
52-Week High | 10.16 |
52-Week Low | 1.92 |
Volume | 26,288 |
Average Volume | 42,932 |
Market Cap | 7.92M |
PE | -1.44 |
EPS | -2.16 |
Moving Average 50 Days | 4.15 |
Moving Average 200 Days | 3.58 |
Change | -0.24 |
If you invested $1000 in Biomerica, Inc. (BMRA) 10 years ago, it would be worth $446.84 as of May 24, 2025 at a share price of $3.11. Whereas If you bought $1000 worth of Biomerica, Inc. (BMRA) shares 5 years ago, it would be worth $58.81 as of May 24, 2025 at a share price of $3.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
GlobeNewswire Inc.
May 22, 2025 12:19 PM GMT
Real-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointestinal pain and a 49.8% reduction in bloating over an 8-week period First-of-Its-Kind inFoods® IBS Feedback Platform: New real
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement
GlobeNewswire Inc.
May 07, 2025 12:19 PM GMT
- Application represents milestone toward broadening patient access to inFoods IBS - inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif. , May 07, 2025
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection
GlobeNewswire Inc.
Apr 23, 2025 12:19 PM GMT
10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproximately 80% of gastric cancer cases are linked to H. pylori infection; WHO classifies H. pylori as a Class 1 carcinogenThis